## AKAM: Akamai Technologies, Inc. - XLK: Technology

### Executive Summary

VALUE thesis: PEG 0.94 indicates fundamental undervaluation. Consistent execution (4/4 quarters beat estimates). Caution: declining volume (53% of avg).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($80.53)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 2
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. Akamai Technologies Announces Acquisition of Function-as-a-Service Company Fermyon**
- Source: CXOToday.com | 20251210T064913 | Bullish | Relevance: 98%
-  Akamai Technologies has acquired Fermyon, a serverless WebAssembly company, to enhance its Akamai Cloud platform with programmable function-as-a-service (FaaS) capabilities at the edge. The acquisition aims to simplify AI and other function deployments, offering improved performance and cost efficiency for edge-native applications. Fermyon's co-founders and employees will join Akamai's Cloud Technology Group, continuing to lead open-source projects and develop next-generation serverless technologies.

**2. Foley Hoag Advises Akamai on Acquisition of Fermyon**
- Source: Foley Hoag | 20251209T180544 | Bullish | Relevance: 97%
-  Foley Hoag advised Akamai Technologies, Inc. (NASDAQ: AKAM) in its recent acquisition of Fermyon Technologies, Inc., a serverless WebAssembly company. Akamai aims to leverage Fermyon's cloud-native WebAssembly function-as-a-service to enhance its edge computing capabilities for artificial intelligence inference. The Foley Hoag team involved in this acquisition was led by Corey Brown and included several other legal professionals.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-17 | Oppenheimer | $100 | $0 | 0% |
| 2025-11-13 | TD Cowen | $104 | $98 | +6% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-17 | Oppenheimer | init | Outperform |
| 2025-11-13 | TD Cowen | main | Hold |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 5 ($2.32M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 92.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 5 |

**Top Holders:**
- Tudor Investment Cor: 51.2% (+100.0%)
- Vanguard Group Inc: 12.8% (-0.3%)
- Blackrock Inc.: 9.8% (-6.3%)
- State Street Corpora: 4.7% (-2.5%)
- First Trust Advisors: 4.0% (-4.4%)

### Key Risks

1. Elevated short interest (11.1%): bears positioning against stock.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.94 indicates undervaluation relative to growth. Forward P/E 11.8x stretched relative to 3% growth. Balance sheet: strong liquidity (2.3x). Analyst sentiment positive (1 raises, avg +6%). Insider selling cluster ($2.3M in 90 days), potential headwind. Institutional flow bullish (4 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $12.3B |
| Beta | 0.68 |
| 52W Range | $67.51 - $103.75 |
| Short Interest | 11.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.94 |
| Forward P/E | 11.8 |
| Current P/E | 12.1 |
| YoY Growth | 3.0% |
| EPS Direction | RISING |

### Technicals

MRS_20 strengthening from -7.1% to -4.3% (+2.8% in 5 days), confirming momentum buildup. Below STRENGTH zone by 8.3pp (needs >4.0% for momentum thesis). MRS_5 turning positive (0.2%) - potential reversal signal. Underperforming sector by 5.5pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.08x) but short-term weakness (below SMA20). MACD histogram bearish (-0.75), momentum weakening. RSI neutral at 51. Volume at 53% of 20MA suggests lack of conviction.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -4.33% (CS: 14) | Weak |
| RSI_14 | 51.4 | Neutral |
| MACD Histogram | -0.75 | Bearish |
| vs SMA20 | 0.978x | Below |
| vs SMA50 | 1.057x | Above |
| vs SMA200 | 1.085x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $85.45
- **Stop Loss:** $80.53 (5.8% risk)
- **Target:** $95.29 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 280
- **Position Value:** $23,926.00
- **Portfolio %:** 23.93%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-02-19 (Est: $1.75)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.64 | $1.86 | +13.7% |
| 2025Q2 | $1.53 | $1.73 | +13.2% |
| 2025Q1 | $1.57 | $1.70 | +8.6% |
| 2024Q4 | $1.52 | $1.66 | +9.0% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*